# Stratification of Risks of Conversion of Radiologically Isolated Syndromes (RIS) by Identifying Biomarkers in Serum and Cerebrospinal Fluid.

> **NCT06395662** · — · ACTIVE_NOT_RECRUITING · sponsor: **Centre Hospitalier Universitaire de Nīmes** · enrollment: 320 (estimated)

## Conditions studied

- Radiologically Isolated Syndrome
- Multiple Sclerosis

## Interventions

- **OTHER:** Observational

## Key facts

- **NCT ID:** NCT06395662
- **Lead sponsor:** Centre Hospitalier Universitaire de Nīmes
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2024-04-15
- **Primary completion:** 2024-12
- **Final completion:** 2025-07
- **Target enrollment:** 320 (ESTIMATED)
- **Last updated:** 2024-11-01

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06395662

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06395662, "Stratification of Risks of Conversion of Radiologically Isolated Syndromes (RIS) by Identifying Biomarkers in Serum and Cerebrospinal Fluid.". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT06395662. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*